Nutraceutical Files For Appellate Court Rehearing Of Ephedra Ban Suit
This article was originally published in The Tan Sheet
Executive Summary
The appellate court decision that upheld FDA's 2004 ephedra ban overextends the agency's authority and blurs the line between food and drug regulation, attorneys for marketer Nutraceutical say in a request for rehearing
You may also be interested in...
Nutraceutical Renews Ephedra Case In Utah Court; FDA To Respond By Jan. 18
FDA did not provide advance notice and opportunity for public comment when it "created a new adulteration standard" in its 2004 final rule banning ephedra alkaloids in dietary supplements, Nutraceutical argues in a motion renewing its case against FDA
Nutraceutical Renews Ephedra Case In Utah Court; FDA To Respond By Jan. 18
FDA did not provide advance notice and opportunity for public comment when it "created a new adulteration standard" in its 2004 final rule banning ephedra alkaloids in dietary supplements, Nutraceutical argues in a motion renewing its case against FDA
Nutraceutical Renews Ephedra Case In Utah Court; FDA To Respond By Jan. 18
FDA did not provide advance notice and opportunity for public comment when it "created a new adulteration standard" in its 2004 final rule banning ephedra alkaloids in dietary supplements, Nutraceutical argues in a motion renewing its case against FDA